Navigation Links
FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer
Date:1/31/2012

SILVER SPRING, Md., Jan. 31, 2012 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors (GIST). Today's action also highlights an increase in overall patient survival when the drug is taken for 36 months rather than the standard 12 months of treatment.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Gleevec was originally granted accelerated approval for the treatment of advanced or metastatic GIST in 2002. In 2008 Gleevec received a subsequent accelerated approval for adjuvant use that is for the treatment of patients with GIST who had had potentially curative resection (surgical removal) of GIST tumors, but who were at increased risk for a recurrence. The accelerated approval program provides earlier patient access to promising new drugs while the confirmatory clinical trials are being conducted. Regular approval for the metastatic GIST indication was also granted in 2008.

GIST is a rare form of cancer that originates in cells found in the wall of the GI tract. These cells, known as interstitial cells of Cajal, are part of the autonomic nervous system, which regulates body processes such as food digestion. More than half of GISTs start in the stomach.

"The development of Gleevec over the past decade highlights the need to further study drugs after approval to truly characterize their benefits," said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the FDA's Center for Drug Evaluation and Research. "Although originally approved in the metastatic disease setting, this subsequent trial has demonstrated that longer use of Gleevec can prolong patient's lives in earlier disease settings."

The label is being updated to include clinical data from a large randomize
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis
2. ASAM Approves Prescription Drug Policy
3. FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing
4. FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments
5. FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
6. FDA Approves Mechanical Cardiac Assist Device for Children With Heart Failure
7. FDA Approves Hologics Cervista High Throughput Automation System for Cervical Cancer Screening
8. FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor
9. FDA Approves First Insomnia Drug for Middle-of-the-Night Waking Followed By Difficulty Returning to Sleep
10. FDA Approves Eylea for Eye Disorder in Older People
11. FDA Approves First Supplemental Test for Chagas Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Oct. 20, 2014  BioPontis Alliance for Rare ... philanthropies, announced today the creation of a joint ... of the rare disease known as Charcot- Marie-Tooth ... alliance model earlier this month. Today,s partnership announcement ... collaborative model where researchers and all CMT dedicated ...
(Date:10/19/2014)... , Oct. 20, 2014 CTI BioPharma Corp. ... will report its third quarter 2014 financial results on ... U.S. financial markets. Following the announcement, members of the ... discuss the results and provide a general corporate update ... the event can be obtained as follows: ...
(Date:10/19/2014)... October 19, 2014 Große ... Das Problem dabei ist, dass große Pharmafirmen ... Kompetenz zu teilen. Es war deshalb ... wir uns umso mehr, dass es uns gelungen ... bei Kühlketten aufzuschreiben - mit einem Vorbehalt - ...
Breaking Medicine Technology:The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 3CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2Vergleichsbericht zu Pharma-Kühlketten und CRT 2
... its entry into the Omaha market today with ... new stores in the city of Omaha.  Joining ... Jim Suttle, Mayor of Omaha and City Councilmember ... http://www.newscom.com/cgi-bin/prnh/20100816/NE50800LOGO) Omaha is the latest market ...
... 16 PLC Systems Inc. (OTC Bulletin Board: ... medical device-based technologies, today reported financial results for the three- ... Second quarter 2010 total revenues were $1,019,000, a decrease ... a decrease of $43,000 from $1,062,000 reported in the first ...
Cached Medicine Technology:CVS/pharmacy Enters Omaha Market 2PLC Systems Reports Second Quarter 2010 Results 2PLC Systems Reports Second Quarter 2010 Results 3PLC Systems Reports Second Quarter 2010 Results 4PLC Systems Reports Second Quarter 2010 Results 5
(Date:10/19/2014)... (PRWEB) October 20, 2014 Having been working ... a good knowledge of customer needs. According to James, one ... covered with dazzling sequins, or with high-low skirts that add ... a huge demand. Recently, LunaDress has unveiled its new selection ... of fact, the company’s brand new items are available in ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that ... announced its latest designs of 2014 mother of ... elegant outfits are offered with big discounts, up to ... October 30 can enjoy this special offer. , ... it has become one of the leading brands in ...
(Date:10/19/2014)... Visual Impact Frequency Training - ... released to the public generating a frenzied buzz ... fitness community. The commotion surrounding the program's launch ... prompting an investigative review. , "Many gym-goers are ... commonly known as a training 'plateau' where they ...
(Date:10/19/2014)... New stem cell-based research could improve understanding of intestinal ... study suggests. Scientists used stem cells to grow ... dish. They then transplanted the organoids into mice, creating ... the researchers. "This provides a new way to ... intestinal failure, from genetic disorders appearing at birth to ...
(Date:10/19/2014)... The U.S. Government has initiated a major effort ... 2025. However, a workgroup of nearly 40 Alzheimer,s ... the U.S. Government,s National Plan to Address Alzheimer,s ... scale, and adequately funded in order to successfully ... the workgroup to enlarge and strengthen the Plan ...
Breaking Medicine News(10 mins):Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 3Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 4Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 5Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 6
... Patients are urged,to suggest candidates for ... participation is vital; many past award winners ... sponsored by the Pennsylvania Academy of Family,Physicians ... provides compassionate, comprehensive care. Eligible nominees must ...
... 16 Americans consume more calories as a,nation on Super ... save,Thanksgiving. By the time the final whistle blows at Super ... greasy pizza,fried chicken wings, and beer., But this year ... of the,football field 109 times to burn off all of ...
... at the Johns Hopkins Brady Urological Institute, Wake Forest University ... of gene markers for hereditary prostate cancer that, along with ... more than nine times that of men without such markers. ... 4,000 Swedes, found that these markers are common and could ...
... history can increase risk up to tenfold, study suggests, , , ... that looks at five genetic variants could one day predict ... , Researchers found that among men with four of the ... percent to 500 percent, compared to men with none of ...
... prevention experts from the University of North Carolina at ... Medicine and Duke University Medical Center will undertake a ... project, the largest and most comprehensive in the country, ... Prevention, the Doris Duke Charitable Foundation and The Duke ...
... cells in the lungs of patients diagnosed with ... death, University of Cincinnati (UC) researchers have discovered. ... of neutrophil (pronounced new-tro-fil) cellsa type of white ... 30 percent increased risk of mortality in the ...
Cached Medicine News:Health News:Nominate Your Family Doctor for Family Physician of the Year 2Health News:Eat This, Not That!(TM): 5 Smart Super Bowl Swaps That Will Save You Hundreds of Calories 2Health News:Gene markers located for hereditary prostate cancer 2Health News:Gene markers located for hereditary prostate cancer 3Health News:Genetic Mutations Boost Prostate Cancer Risk 2Health News:Genetic Mutations Boost Prostate Cancer Risk 3Health News:UNC, Duke lead first statewide shaken baby prevention research project in US 2Health News:UNC, Duke lead first statewide shaken baby prevention research project in US 3Health News:UNC, Duke lead first statewide shaken baby prevention research project in US 4Health News:Rare lung disease cells indicate higher death risk 2
... benefits from innovative research in materials and ... as the aerospace and automotive industry, the ... the footwear and textile industry. , ,This ... the Carrera sunglasses collection to create unique ...
Safilo Design, a state-of-the art ophthalmic collection that blends technology with minimalist sophistication. Each style comes with a sleek silver-colored hard case with magnetic closure....
Inquire...
The latest VALENTINO eyewear collection is a refined expression of sophisticated luxury,balancing ultimate feminine, chic styles against understated, minimalist mens models....
Medicine Products: